Gland Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

1,894.74

1,905.21

2,166.34

2,234.37

1,715.71

Operating profit

606.46

565.44

697.70

812.94

710.32

Interest

2.51

2.62

3.22

2.03

1.23

Gross profit

680.27

702.84

805.39

923.95

761.52

EPS (Rs)

27.03

28.48

34.05

39.75

32.61

Other income

76.32

140.02

110.90

113.04

52.43

Stock adjustment

-43.23

45.63

-32.35

69.04

-161.66

Raw material

848.43

845.18

1,067.54

979.33

845.90

Power and fuel

-

-

25.13

-

-

Employee expenses

202.79

199.16

175.68

162.89

150.90

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

280.29

249.80

232.65

210.18

170.26

Provisions made

-

-

-

-

-

Depreciation

79.22

71.58

58.91

51.39

48.89

Taxation

155.95

162.17

187.12

219.77

180.18

Net profit / loss

445.11

469.08

559.36

652.80

532.45

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

16.47

16.47

16.43

16.42

16.33

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

32.01

29.68

32.21

36.38

41.40

GPM (%)

34.51

34.36

35.37

39.36

43.07

NPM (%)

22.58

22.94

24.56

27.81

30.11